Blog

Rare melanoma type highly responsive to immunotherapy – EurekAlert (press release)

Rare melanoma type highly responsive to immunotherapy
EurekAlert (press release)
However, based on anecdotal reports of favorable responses, a group of researchers including Moffitt's Zeynep Eroglu, M.D., Jane Messina, M.D., and Dae Won Kim, M.D., hypothesized that patients with desmoplastic melanoma may be more responsive to anti
Immunotherapy Highly Effective in Treatment of Rare Skin Cancer, Study FindsNewswise (press release)



all 2 news articles »

2018-01-10 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.